New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.
3monon MSN
In the quest to enhance the efficacy of chimeric antigen receptor T (CAR-T) cell therapy against hepatocellular carcinoma ...
Danés, principal investigator of the Cancer and Stem Cell Biology Lab at the Champalimaud Foundation, in Lisbon, has shown ...
A new prognostic model could potentially predict and stratify the risk for hepatocellular carcinoma (HCC) among patients with chronic hepatitis B (CHB) who are noncirrhotic and not indicated for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback